Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
Patent 5576353 Issued on November 19, 1996. Estimated Expiration Date: 
June 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3201470 3253037 3513244 Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof Propargyl amino compounds Patent #: 5196583 InventorsAssigneeApplicationNo. 459402 filed on 06/02/1995US Classes:514/647, Amino nitrogen and a ring bonded directly to the same ring and any other amino nitrogen in the compound is bonded directly to one of the rings514/567, Benzene ring nonionically bonded514/614, N-N containing (e.g., aminimine, hydrazine, etc.)564/308Polycyclo ring systemExaminersPrimary: Burn, Brian M.Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/135Foreign Application Priority Data1990-01-03 ILAbstractR(+)-N-propargyl-1-aminoindan, its preparation and use and pharmaceutical compositions containing it. The novel compound was found to be useful for the treatment of human patients for Parkinson's disease, memory disorders, dementia of the Alzheimer type (DAT), depression and the hyperactive syndrome.Other References
|
| ||||||||||||||
